Editorial · 2025 · Open access
THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES
International Journal of Pharmacy & Integrated Health Sciences, 6(2), 1–3 · Published 1 September 2025 · DOI 10.56536/ijpihs.v6i2.304
In brief
“THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES” is an 2025 editorial by Abubakar Munir, published in International Journal of Pharmacy & Integrated Health Sciences. OpenAlex counts 2 citations as of 15 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at International Journal of Pharmacy & Integrated Health Sciences.
- Citations
- 2
- Most cited in
- 2025 (1)
- References
- 8
- Authors
- 1
Abstract
The PRISMA 2020 statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) represents a major revision of the earlier 2009 guideline, with the explicit goal of strengthening completeness, transparency, and consistency in the reporting of systematic reviews. Systematic reviews and meta-analyses have become indispensable in modern health sciences, enabling researchers and policymakers to synthesize large volumes of primary studies into clear, evidence-based conclusions. They underpin clinical guidelines, inform health policy, and guide future research. Yet their value depends on the clarity, completeness, and transparency of their reporting. Historically, many published reviews have suffered from incomplete or ambiguous descriptions of search strategies, inclusion criteria, study selection processes, and synthesis methods. Such omissions make it difficult for readers to appraise the review’s credibility, replicate its findings, or update it in light of new evidence. Recognizing these shortcomings, the scientific community has developed structured reporting guidelines—most notably the PRISMA statement, first introduced in 2009 (1-3). In March 2021, PRISMA was updated to PRISMA 2020, incorporating advances in methodology, technology, and terminology that have emerged over the past decade. This editorial outlines the rationale, core components, and implications of PRISMA 2020, and formally endorses its adoption for systematic review and meta-analysis submissions to our journal, the International Journal of Pharmacy and Integrated Health Sciences (IJPIHS). The release of PRISMA 2020 also marks a moment of transition within the field. At the same time, the revision highlights the emergence of a new generation of international leaders who now take up the responsibility of advancing and refining the standards for systematic review reporting (4,5).
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Munir, A. (2025). THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES. International Journal of Pharmacy & Integrated Health Sciences, 6(2), 1–3. https://doi.org/10.56536/ijpihs.v6i2.304
MLA 9
Munir, Abubakar. “THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES.” International Journal of Pharmacy & Integrated Health Sciences, vol. 6, no. 2, 2025, pp. 1–3. https://doi.org/10.56536/ijpihs.v6i2.304.
Chicago
Munir, Abubakar. 2025. “THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES.” International Journal of Pharmacy & Integrated Health Sciences 6 (2): 1–3. https://doi.org/10.56536/ijpihs.v6i2.304.
Harvard
Munir, A. (2025) ‘THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES’, International Journal of Pharmacy & Integrated Health Sciences, 6(2), pp. 1–3. doi:10.56536/ijpihs.v6i2.304.
IEEE
A. Munir, “THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES,” International Journal of Pharmacy & Integrated Health Sciences, vol. 6, no. 2, pp. 1–3, 2025, doi: 10.56536/ijpihs.v6i2.304.
BibTeX
@article{munir2025prisma,
title = {{THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES}},
author = {Munir, Abubakar},
journal = {International Journal of Pharmacy \& Integrated Health Sciences},
year = {2025},
volume = {6},
number = {2},
pages = {1--3},
doi = {10.56536/ijpihs.v6i2.304},
url = {https://doi.org/10.56536/ijpihs.v6i2.304}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- PRISMA 2020
- meta-analysis reporting
- reporting transparency
- reporting completeness
- search strategy reporting
- inclusion criteria
- study selection
Work with this paper
Most-cited papers in Decision Sciences
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew James Page, Joanne E. McKenzie, Patrick M. Bossuyt and 23 more · BMJ · 2021 · 144,919 citations
- Evaluating Structural Equation Models with Unobservable Variables and Measurement ErrorClaes Fornell, David F. Larcker · Journal of Marketing Research · 1981 · 118,336 citations
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesLi‐tze Hu, Peter M. Bentler · Structural Equation Modeling A Multidisciplinary Journal · 1999 · 117,461 citations
- Common method biases in behavioral research: A critical review of the literature and recommended remedies.Philip M. Podsakoff, SCOTT B. MACKENZIE, Jeong Yeon Lee and 1 more · Journal of Applied Psychology · 2003 · 89,248 citations
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementDavid Moher, Alessandro Liberati, Jennifer Tetzlaff and 2 more · BMJ · 2009 · 85,524 citations
Questions about this paper
How do I cite this paper in APA style?
Munir, A. (2025). THE PRISMA 2020 STATEMENT: A COMPREHENSIVE GUIDELINE FOR SYSTEMATIC REVIEW-BASED PERSPECTIVES. International Journal of Pharmacy & Integrated Health Sciences, 6(2), 1–3. https://doi.org/10.56536/ijpihs.v6i2.304
How many times has this paper been cited?
2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at International Journal of Pharmacy & Integrated Health Sciences.
Who wrote this paper?
Abubakar Munir.
What is the DOI of this paper?
10.56536/ijpihs.v6i2.304. The permanent link is https://doi.org/10.56536/ijpihs.v6i2.304.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.